Income statement
USD
Annual
| Metric | 2022 | 2021 | 2020 | 2019 | 2012 |
|---|---|---|---|---|---|
| Revenue | 8M | 13M | 12M | 0 | 105K |
| Gross Profit | 712K | 2M | 1M | -2K | 68K |
| Operating Income | 381K | 2M | 683K | -2K | -311K |
| EBITDA | 520K | 2M | 857K | -326 | -71K |
| Net Income | 15K | 996K | 299K | -2K | -282K |
| EPS (Diluted) | — | — | — | — | — |
Real Estate
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Extreme Biodiesel, Inc. (XTRM) is a Real Estate stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of -37.8%, EPS growth of -99.0%, a dividend yield of 0.0%. What stands out right now is revenue -37.8%, EPS -99.0%, free cash flow +190.7% with operating margin 4.5% and ROIC 4.4%. Valuation is more restrained than many high-expectation growth names at P/E 12.0 and price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines XTRM price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Real Estate peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
XTRM
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
XTRM Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for XTRM and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$105.3K
FY Net Income
-$282.1K
-13319.7% YoY
Free Cash Flow
-$25.1K
-69483.3% YoY
Revenue Growth
-37.8%
EPS Growth
-99.0%
Gross Margin
8.5%
Net Margin
0.2%
Income statement
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2012 |
|---|---|---|---|---|---|
| Revenue | 8M | 13M | 12M | 0 | 105K |
| Gross Profit | 712K | 2M | 1M | -2K | 68K |
| Operating Income | 381K | 2M | 683K | -2K | -311K |
| EBITDA | 520K | 2M | 857K | -326 | -71K |
| Net Income | 15K | 996K | 299K | -2K | -282K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2012 |
|---|---|---|---|---|---|
| Cash & Equivalents | 42K | 226K | 194K | 183 | 2K |
| Total Assets | 9M | 10M | 7M | 4K | 674K |
| Total Liabilities | 7M | 8M | 6M | 1K | 561K |
| Shareholder Equity | 2M | 2M | 506K | 3K | 113K |
| Total Debt | 6M | 8M | 6M | 0 | 236K |
| Net Debt | 6M | 7M | 6M | -183 | 234K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
25K
-69483.3% YoY
Capital Expenditures
0
Free Cash Flow
25K
-69483.3% YoY
Key ratios
Gross Margin
8.5%
Operating Margin
4.5%
Net Margin
0.2%
ROE
0.7%
Debt / Equity
2.98x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.